These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 25016155)

  • 1. Interactions of isoniazid with membrane models: implications for drug mechanism of action.
    Pinheiro M; Silva AS; Pisco S; Reis S
    Chem Phys Lipids; 2014 Oct; 183():184-90. PubMed ID: 25016155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the effect of rifampicin on the biophysical properties of the membranes: significance for therapeutic and side effects.
    Pinheiro M; Pisco S; Silva AS; Nunes C; Reis S
    Int J Pharm; 2014 May; 466(1-2):190-7. PubMed ID: 24607210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-drug interaction: biophysical effects of tolmetin on membrane mimetic systems of different dimensionality.
    Nunes C; Brezesinski G; Lopes D; Lima JL; Reis S; Lúcio M
    J Phys Chem B; 2011 Nov; 115(43):12615-23. PubMed ID: 21936545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular interactions of rifabutin with membrane under acidic conditions.
    Pinheiro M; Silva AS; Reis S
    Int J Pharm; 2015 Feb; 479(1):63-9. PubMed ID: 25542991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synchrotron SAXS and WAXS study of the interactions of NSAIDs with lipid membranes.
    Nunes C; Brezesinski G; Lima JL; Reis S; Lúcio M
    J Phys Chem B; 2011 Jun; 115(24):8024-32. PubMed ID: 21598995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NSAIDs interactions with membranes: a biophysical approach.
    Nunes C; Brezesinski G; Pereira-Leite C; Lima JL; Reis S; Lúcio M
    Langmuir; 2011 Sep; 27(17):10847-58. PubMed ID: 21790169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of celecoxib with membranes: the role of membrane biophysics on its therapeutic and toxic effects.
    Pereira-Leite C; Nunes C; Lima JL; Reis S; Lúcio M
    J Phys Chem B; 2012 Nov; 116(46):13608-17. PubMed ID: 23094761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of antitubercular drug insertion into preformed dipalmitoylphosphatidylcholine monolayers.
    Chimote G; Banerjee R
    Colloids Surf B Biointerfaces; 2008 Apr; 62(2):258-64. PubMed ID: 18082382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcein release behavior from liposomal bilayer; influence of physicochemical/mechanical/structural properties of lipids.
    Maherani B; Arab-Tehrany E; Kheirolomoom A; Geny D; Linder M
    Biochimie; 2013 Nov; 95(11):2018-33. PubMed ID: 23871914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between O-carboxymethylchitosan and dipalmitoyl-sn-glycero-3-phosphocholine bilayer.
    Zhu AP; Fang N; Chan-Park MB; Chan V
    Biomaterials; 2005 Dec; 26(34):6873-9. PubMed ID: 15972235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of inhalable isoniazid-loaded surfactant liposomes as an adjunct therapy in pulmonary tuberculosis.
    Chimote G; Banerjee R
    J Biomed Mater Res B Appl Biomater; 2010 Jul; 94(1):1-10. PubMed ID: 20524179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biocompatible cationic lipids for the formulation of liposomal DNA vectors.
    Montis C; Sostegni S; Milani S; Baglioni P; Berti D
    Soft Matter; 2014 Jun; 10(24):4287-97. PubMed ID: 24788854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of rifabutin on human and bacterial membrane models: implications for its mechanism of action.
    Pinheiro M; Nunes C; Caio JM; Moiteiro C; Lúcio M; Brezesinski G; Reis S
    J Phys Chem B; 2013 May; 117(20):6187-93. PubMed ID: 23617457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encapsulation of Rifampicin in a solid lipid nanoparticulate system to limit its degradation and interaction with Isoniazid at acidic pH.
    Singh H; Bhandari R; Kaur IP
    Int J Pharm; 2013 Mar; 446(1-2):106-11. PubMed ID: 23410991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a novel antimycobacterial compound on the biophysical properties of a pulmonary surfactant model membrane.
    Pinheiro M; Arêde M; Giner-Casares JJ; Nunes C; Caio JM; Moiteiro C; Lúcio M; Camacho L; Reis S
    Int J Pharm; 2013 Jun; 450(1-2):268-77. PubMed ID: 23603451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and calorimetrical studies of the effect of different aminoglycosides on DPPC liposomes.
    Oszlánczi A; Bóta A; Czabai G; Klumpp E
    Colloids Surf B Biointerfaces; 2009 Feb; 69(1):116-21. PubMed ID: 19118988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proof of pore formation and biophysical perturbations through a 2D amoxicillin-lipid membrane interaction approach.
    Lopes D; Nunes C; Fontaine P; Sarmento B; Reis S
    Biochim Biophys Acta Biomembr; 2017 May; 1859(5):803-812. PubMed ID: 28159461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-membrane interaction studies applied to N'-acetyl-rifabutin.
    Pinheiro M; Arêde M; Caio JM; Moiteiro C; Lúcio M; Reis S
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):597-603. PubMed ID: 23523541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermally gated liposomes.
    Chen WH; Regen SL
    J Am Chem Soc; 2005 May; 127(18):6538-9. PubMed ID: 15869267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solubilization of negatively charged DPPC/DPPG liposomes by bile salts.
    Hildebrand A; Beyer K; Neubert R; Garidel P; Blume A
    J Colloid Interface Sci; 2004 Nov; 279(2):559-71. PubMed ID: 15464825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.